Sagimet Biosciences (SGMT) Amortizatization of Intangibles (2022 - 2026)

Sagimet Biosciences' (SGMT) quarterly Amortizatization of Intangibles came in at $140000.0 in Q1 2026, down 73.83% year-on-year from $535000.0 in Q1 2025, and up 146.67% quarter-over-quarter from -$300000.0 in Q4 2025.

Sagimet Biosciences (SGMT) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Sagimet Biosciences' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $140000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 73.83% year-over-year to $140000.0 in Q1 2026; TTM through Mar 2026 was -$6000.0, a 100.38% decrease from a year earlier, with the FY2025 full-year figure at $389000.0, down 68.95% from the prior year.
  • Amortizatization of Intangibles climbed to $140000.0 in Q1 2026 per SGMT's latest filing, from -$300000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $535000.0 in Q1 2025 and bottomed at -$300000.0 in Q4 2025.
  • The 5-year median for Amortizatization of Intangibles is $85500.0 (2022), against an average of $142142.9.
  • Across the five-year window, Amortizatization of Intangibles surged 11825.0% in 2024 and tumbled 635.71% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $83000.0 in 2022, then plunged by 102.41% to -$2000.0 in 2023, then jumped by 2900.0% to $56000.0 in 2024, then tumbled by 635.71% to -$300000.0 in 2025, then jumped by 146.67% to $140000.0 in 2026.
  • Per Business Quant, the three latest SGMT Amortizatization of Intangibles figures stand at $140000.0 (Q1 2026), -$300000.0 (Q4 2025), and -$72000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 3.22 Mn
10 Sagimet Biosciences 227.27 Mn 227.27 Mn - 140,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 140,000.00
Mar 31, 2026 140,000.00
Dec 31, 2025 -300,000.00
Dec 31, 2025 -300,000.00
Sep 30, 2025 -72,000.00
Sep 30, 2025 -72,000.00
Jun 30, 2025 226,000.00
Jun 30, 2025 226,000.00
Mar 31, 2025 535,000.00
Mar 31, 2025 535,000.00
Dec 31, 2024 56,000.00
Dec 31, 2024 56,000.00
Sep 30, 2024 527,000.00
Sep 30, 2024 527,000.00
Jun 30, 2024 477,000.00
Jun 30, 2024 477,000.00
Mar 31, 2024 193,000.00
Mar 31, 2024 193,000.00
Dec 31, 2023 -2,000.00
Dec 31, 2023 -2,000.00